Contract for the supply of live attenuated intranasal influenza vaccine

The provision of a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. The volume requirement is 3,364,470 doses of vaccine. Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.